Canada contributes over U$ 11 million to PAHO’s effort to enhance the local production of vaccines

Washington, D.C., November 21, 2022 (PAHO)– The Government of Canada has actually revealed a $15 million Canadian dollar contribution (comparable to US$ 11.2 million) towards a Pan American Health Organization (PAHO) effort to increase vaccine production capabilities in Latin America and the Caribbean. Released in 2021, the PAHO Regional Platform to Advance the Manufacturing of COVID-19 Vaccines and other Health Technologies in the Americas intends to increase the area’s capability to react quicker and autonomously to health emergency situations and to enhance access to much required vaccines, medications, and other medical materials. “We thank the Government of Canada for this generous and prompt contribution, which will be essential in making the area much better gotten ready for future obstacles,” PAHO’s Director Carissa F. Etienne stated. The COVID-19 health crisis exposed significant rifts in access to healthcare and exposed the area’s high reliance on imports for vaccines, medications and other medical materials. Nations with regional production capability were the very first to gain from COVID-19 vaccines, however much of Latin America and the Caribbean needed to await these to appear from central external producers, causing substantial hold-ups in the rollout of projects to secure lives. “This variation highlighted the requirement to purchase efforts to diversify the production of vaccines and their elements throughout nations,” the PAHO Director stated, while benefiting from brand-new health innovations, such as messenger RNA (mRNA) vaccines that can be utilized beyond COVID-19 “Canada is pleased to support PAHO’s ingenious work to reinforce vaccine production capabilities in Latin America and the Caribbean and to deepen our collaboration on this vital concern for the area,” Ambassador Hugh Adsett, Permanent Representative of Canada to the Organization of American States stated. Structure on existing capabilities in the area, the PAHO effort will support training and innovation transfer, reinforce local worth chains to source the needed elements for vaccine production, and reinforce regulative systems and making it possible for functions for vaccines production. As part of the PAHO effort, in September 2021 Bio-Manguinhos/FIOCRUZ in Brazil and Sinergium Biotech in Argentina were chosen to be part of an innovation transfer effort for the advancement and production of mRNA-based vaccines in the area. Agents from both organizations participated of a training at the World Health Organization mRNA international center, Afrigen Biologics, to speed up the advancement of the innovation in the area.
Read More